Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Leroy

Showing results (61-70 of 172) with videos related to

Pageof 18
Sort By:
Plos One|June 28, 2016
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg SeroconversionJuliana Bruder Costa, Tania Dufeu-Duchesne, Vincent Leroy, et al.
Clinical Transplantation|February 27, 2013
Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explantsMélanie Vallin, Nathalie Sturm, Géraldine Lamblin, et al.
Scientific Reports|November 10, 2018
Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary DiseaseDamien Viglino, Anais Plazanet, Sebastien Bailly, et al.
The Journal of Infectious Diseases|July 22, 2025
Virological tools fail to properly identify "unusual" hepatitis C virus subtypes resistant to direct-acting antiviral drugs in The GambiaErwan Vo-Quang, Christophe Rodriguez, Arnaud Ly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 22, 2008
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis CPaul Calès, Victor de Ledinghen, Philippe Halfon, et al.
Clinical & Translational Immunology|December 14, 2020
Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCsLaurissa Ouaguia, Tania Dufeu-Duchesne, Vincent Leroy, et al.
Journal of Clinical Medicine|September 10, 2021
Impact of the <sup>18</sup>F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 PatientsMathilde Vermersch, Sébastien Mulé, Julia Chalaye, et al.
Clinics and Research in Hepatology and Gastroenterology|March 20, 2018
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacyVictor Virlogeux, Pascale Berthillon, Isabelle Bordes, et al.
European Journal of Gastroenterology & Hepatology|December 9, 2008
Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis CJérôme Boursier, Yannick Bacq, Philippe Halfon, et al.
Molecular Cancer Therapeutics|June 2, 2017
Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular CarcinomaGaël S Roth, Zuzana Macek Jilkova, Ayca Zeybek Kuyucu, et al.
Pageof 18

Showing results (61-70 of 172) with videos related to

Sort By:
Pageof 18
Plos One|June 28, 2016
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg SeroconversionJuliana Bruder Costa, Tania Dufeu-Duchesne, Vincent Leroy, et al.
Clinical Transplantation|February 27, 2013
Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explantsMélanie Vallin, Nathalie Sturm, Géraldine Lamblin, et al.
Scientific Reports|November 10, 2018
Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary DiseaseDamien Viglino, Anais Plazanet, Sebastien Bailly, et al.
The Journal of Infectious Diseases|July 22, 2025
Virological tools fail to properly identify "unusual" hepatitis C virus subtypes resistant to direct-acting antiviral drugs in The GambiaErwan Vo-Quang, Christophe Rodriguez, Arnaud Ly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 22, 2008
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis CPaul Calès, Victor de Ledinghen, Philippe Halfon, et al.
Clinical & Translational Immunology|December 14, 2020
Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCsLaurissa Ouaguia, Tania Dufeu-Duchesne, Vincent Leroy, et al.
Journal of Clinical Medicine|September 10, 2021
Impact of the <sup>18</sup>F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 PatientsMathilde Vermersch, Sébastien Mulé, Julia Chalaye, et al.
Clinics and Research in Hepatology and Gastroenterology|March 20, 2018
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacyVictor Virlogeux, Pascale Berthillon, Isabelle Bordes, et al.
European Journal of Gastroenterology & Hepatology|December 9, 2008
Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis CJérôme Boursier, Yannick Bacq, Philippe Halfon, et al.
Molecular Cancer Therapeutics|June 2, 2017
Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular CarcinomaGaël S Roth, Zuzana Macek Jilkova, Ayca Zeybek Kuyucu, et al.
Pageof 18